PHMMF OTC
Pharma Mar, S.A.
1W: +0.0%
1M: +0.0%
3M: +19.0%
YTD: +9.7%
1Y: -7.5%
3Y: +193.2%
5Y: +10.3%
$94.60
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$395M
+13.0% ▲
5Y CAGR: +3.6%
Total Liabilities
$142M
+0.8% ▲
5Y CAGR: -8.9%
Shareholders Equity
$252M
+20.8% ▲
5Y CAGR: +19.6%
Cash & Investments
$167M
+8.2% ▲
5Y CAGR: -3.1%
Total Debt
$51M
-1.1% ▼
5Y CAGR: -2.3%
Net Debt
$33M
+369.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $113M | $150M | $60M | $63M | $18M |
| Short-Term Investments | $89M | $33M | $103M | $91M | $149M |
| Cash & ST Investments | $202M | $182M | $163M | $155M | $167M |
| Net Receivables | $79M | $29M | $28M | $35M | $61M |
| Inventory | $11M | $28M | $39M | $51M | $54M |
| Other Current Assets | $28M | $30M | $20M | $7M | $4 |
| Total Current Assets | $295M | $275M | $253M | $250M | $283M |
| Property, Plant & Equip. | $31M | $35M | $48M | $59M | $60M |
| Goodwill & Intangibles | $3M | $3M | $2M | $1M | $4M |
| Long-Term Investments | -$78M | $17M | $6M | -$89M | $1M |
| Other Non-Current Assets | $89M | $33M | $2M | $92M | $3 |
| Total Non-Current Assets | $73M | $118M | $89M | $99M | $112M |
| Total Assets | $368M | $393M | $341M | $350M | $395M |
| — Liabilities — | |||||
| Accounts Payable | $27M | $27M | $29M | $39M | $54M |
| Short-Term Debt | $12M | $13M | $13M | $8M | $13M |
| Deferred Revenue | $40M | $26M | $0 | $0 | $5M |
| Other Current Liabilities | $36M | $45M | $40M | $31M | $19M |
| Total Current Liabilities | $86M | $97M | $96M | $83M | $94M |
| Long-Term Debt | $33M | $26M | $27M | $40M | $37M |
| Other Non-Current Liab. | $186K | $186K | $896K | $194K | -$1M |
| Total Non-Current Liabilities | $104M | $73M | $52M | $59M | $49M |
| Total Liabilities | $190M | $170M | $147M | $141M | $142M |
| — Equity — | |||||
| Common Stock | $11M | $11M | $11M | $11M | $11M |
| Retained Earnings | $121M | $157M | $142M | $168M | $234M |
| Accumulated OCI | $38K | $19K | $15K | $16K | $18K |
| Total Stockholders Equity | $178M | $223M | $193M | $208M | $252M |
| Total Liabilities & Equity | $368M | $393M | $341M | $350M | $395M |
| — Key Metrics — | |||||
| Total Debt | $49M | $43M | $44M | $51M | $51M |
| Net Debt | -$64M | -$107M | -$16M | -$12M | $33M |
| Total Investments | $11M | $49M | $109M | $2M | $151M |